article thumbnail

Can pharma really leverage social media?

World of DTC Marketing

Tik-Tok, Instagram, and other social media channels may soon be overwhelmed with pharma companies’ content, but is it a good idea? Pharma companies have policies that heavily restrict their use of social media and limit their ability to benefit from the wealth of data that could accompany it. What about social media options?

Media 305
article thumbnail

Pharma’s paid media fails

World of DTC Marketing

At the center of The Citizen Browser Project is a custom web browser designed by The Markup to audit the algorithms that social media platforms use to determine what information they serve their users, what news and narratives are amplified or suppressed, and which online communities those users are encouraged to join.

Media 306
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

The social media problem for healthcare

World of DTC Marketing

The research that seems to be lacking is what online health seekers are doing due to researching online health information on social media. The post The social media problem for healthcare. From my estimates, most of it failed because pharma companies are afraid of misinformation concerning regulations around DTC marketing.

Media 297
article thumbnail

4 pioneering social media campaigns in pharma this year

PharmaVoice

The key to a great social media campaign is often simplicity, and these pharma companies hit the nail on the head with unique strategies that aim to educate.

Media 278
article thumbnail

With TV ads under threat, here’s how pharma can leverage social media

PharmaVoice

’s plan to ban TV advertising may shift more marketing attention to online platforms.

Media 182
article thumbnail

Patients are using social media — clinical trial experts can learn from that

PharmaVoice

Why an alliance of industry leaders is exploring the potential of social media as a treasure trove of real-world patient experience insights.

Media 246
article thumbnail

Despite high-profile media coverage, FDA balks at GSK's 'unprecedented' Jemperli proposal in rectal cancer

Fierce Pharma

Despite high-profile media coverage, FDA balks at GSK's 'unprecedented' Jemperli proposal in rectal cancer aliu Tue, 02/07/2023 - 17:07

Media 262